Expert Panel recommends CoronaVac on elderly

Marje Pelayo   •   April 7, 2021   •   213

MANILA, Philippines — The country’s vaccine expert panel has recommended the use of CoronaVac, the COVID-19 vaccine produced by China’s Sinovac BioTech, for individuals aged 60 years old and above.

This, after AstraZeneca’s COVID-19 vaccine supply has reportedly begun to run out.

According to Vaccine Development Expert Panel Head Dr. Nina Gloriani, CoronaVac manifested positive results based on their evaluation citing the vaccine’s safety profile.

“We are just talking about senior citizens. Maganda ang kaniyang safety profile. Mild to moderate ang symptoms based doon sa pagaaral sa Brazil, although konti ang senior na napasama duon sa study,” Dr.Gloriani said.

In Brazil, around 400 senior citizens have taken the CoronaVac shots and 422 elderly had it during the trial.

Dr. Gloriani said all subjects in the study showed only mild to moderate side effects and minimal pain due to injection.

“Ang maganda duon sa datos na nakita namin ay nakakaprotekta din siya sa mga matatanda. Nagkakaroon ng mild pero hindi sila nagkaroon ng severe (symptoms),” the expert noted.

It can be recalled that when Sinovac was granted emergency use authorization (EUA) for CoronaVac, the Food and Drug Administration (FDA) did not recommend using it on senior citizens due to a lack of studies.

PH receives 500K more Sinovac COVID-19 vaccines

Robie de Guzman   •   April 23, 2021

MANILA, Philippines – The Philippines on Thursday received another shipment of COVID-19 vaccines manufactured by Chinese firm Sinovac Biotech.

Around 500,000 doses of COVID-19 vaccines purchased by the government arrived at the Ninoy Aquino International Airport at past 5 p.m. It arrived via a Philippines Airlines flight.

The shipment brings the COVID-19 shots so far delivered to the country to more than 3,525,600, comprised of CoronaVac and AstraZeneca.

This is part of the commitment of Sinovac Biotech to deliver 1.5 million vaccine doses this month. The other 500,000 doses were shipped last April 11.

Vaccine czar Carlito Galvez Jr. earlier said that about 100,000 of these vaccines will be deployed to Metro Manila and its administration will be completed within the week.

Galvez also said that another 500,000 doses of Sinovac vaccines will be delivered on April 29.

500K more Sinovac doses to arrive in PH April 22

Robie de Guzman   •   April 22, 2021

MANILA, Philippines – The Philippines is set to receive Thursday 500,000 more doses of CoronaVac COVID-19 vaccines from Chinese firm Sinovac Biotech.

The plane carrying the shipment is expected to arrive at the Ninoy Aquino International Airport around 5 p.m.

Vaccine czar Carlito Galvez Jr., Health Secretary Francisco Duque III and other officials will welcome the arrival of the vaccines procured by the government.

The arrival of the additional doses on Thursday would bring to 3,525,600 the number of COVID-19 vaccines, comprised of CoronaVac and AstraZeneca, that the Philippines has so far received.

Philippine Ambassador to China Jose Santiago Sta. Romana on Wednesday announced that another 500,000 vials of Sinovac vaccines are expected to arrive in Manila next week.

This is part of the commitment of Sinovac Biotech to deliver 1.5 million vaccine doses this month. The other 500,000 doses were shipped last April 11.

The Philippines is also expecting to receive this month at least 20,000 doses of Sputnik V vaccines made by Russia’s Gamaleya Institute while additional AstraZeneca COVID-19 vaccine doses from the World Health Organization (WHO)-led COVAX Facility may be delivered in May.

The WHO previously said that the delivery of the AstraZeneca vaccine doses for the Philippines has been delayed, and that it will be lesser in number than expected, due to a global supply shortage.

Once additional vaccine doses arrive in the country, the national government is eyeing to begin the inoculation of economic frontliners by May and to intensify the vaccination drive in other COVID-19 hotspots in the Philippines.

Alamin: Bakit maari pa ring mahawa ang isang taong nabakunahan na laban sa COVID-19?

Marje Pelayo   •   April 14, 2021

MANILA, Philippines — Patuloy ang paalala ng Department of Health (DOH) sa publiko maging sa mga indibidwal na nakakumpleto na ng dalawang dosage ng COVID-19 vaccines na mag-ingat dahil posible pa rin silang mahawa ng virus.

Paliwanag ng DOH, patuloy pang pinag-aaralan ang pagiging epektibo ng bakuna at wala pang sapat na ebidensya kung kailan makukuha ng isang indibidwal ang ganap na proteksyon pagkatapos na makapagpabakuna.

Ayon sa DOH at maging ng mga vaccine expert, proteksyon sa pagkakaroon ng severe case ng coronavirus disease ang maibibigay ng mga COVID-19 vaccines sa ngayon at hindi ang immunity sa pagkakahawa sa virus.

“Ang sinasabi natin, lahat ng bakuna na available ngayon for EUA ay wala silang kapasidad para mag-block ng transmission. Ibig sabihin, kahit ikaw ay bakunado na even with your second dose you can still be infected and you can still infect others,” paliwanag ni Health Undersecretary Maria Rosario Vergeire.

Sa kasalukuyan, ilang bansa gaya ng Singapore at Japan ang nakapagtala na ng mga indibidwal na nahawa pa rin sa COVID-19 ilang araw pagkatapos na mabakunahan ng bakunang Pfizer-BionTech.

Kaya naman pinag-iingat pa rin ng DOH ang mga nakakumpleto na ng two dosage ng COVID-19 vaccines at sumunod pa rin sa health protocols dahil hanggang ngayon ay patuloy pang pinag-aaralan kung kailan makukuha ng isang indibidwal na nabakunahan ang ganap na proteksyon nito sa katawan.

“Wala pang lumalabas na sufficient evidence to state how much time does these vaccines give as protection. mayroon pailan-ilang studies lumalabas up to three months up to six months pero wala pa talagang sufficient na ebidensya at wala pa ring ibinibigay na rekomendasyon ang (World Health Organization),” ayon kay Vergeire.

Ngunit paliwanag ng mga vaccine expert, kung mahahawa man ang indibidwal na naka-kumpleto na ng COVID-19 vaccine, hindi naman ito magkakaroon ng severe cases ng sakit.

Base sa evaluation ng Food and Drug Administration (FDA), ang bakunang CoronaVac ng Sinovac ay may 100 percent efficacy rate laban sa pagkakaroon ng severe case; 50 percent laban sa mild cases; at 83 percent sa moderate cases.

Ang bakunang AstraZeneca naman ay may 100 percent efficacy rate upang protektahan ang isang indibidwal sa pagkakaroon ng moderate to severe cases ng COVID-19.

“Again I reiterate that it may not prevent you from getting an infection but it will suddenly prevent you from severe disease and death,” concluded Dr. Ruby Pawankar, president of the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI). MNP (sa ulat ni Harlene Delgado)

REACH US

The Philippine Broadcast Hub

UNTV, 915 Barangay Philam,

EDSA, Quezon City M.M. 1104

(+632) 8396-8688 (Tel)

info@untv-newsandrescue.com (General inquiries)

ABOUT UNTV

UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.